IL-33 inhibits tumor growth through the activation of anti-tumor CD8+ T cell response in hepatocellular carcinoma

被引：0
|
作者：
Jin, Ziqi [1 ]
Liu, Haiyan [2 ]
机构：
[1] Soochow Univ, Suzhou, Peoples R China
[2] Natl Univ Singapore, Singapore, Singapore
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
57.4
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
    DeVorkin, Lindsay
    Pavey, Nils
    Carleton, Gillian
    Comber, Alexandra
    Ho, Cally
    Lim, Junghyun
    McNamara, Erin
    Huang, Haochu
    Kim, Paul
    Zacharias, Lauren G.
    Mizushima, Noboru
    Saitoh, Tatsuya
    Akira, Shizuo
    Beckham, Wayne
    Lorzadeh, Alireza
    Moksa, Michelle
    Cao, Qi
    Murthy, Aditya
    Hirst, Martin
    DeBerardinis, Ralph J.
    Lum, Julian J.
    CELL REPORTS, 2019, 27 (02): : 502 - +
  • [22] How tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
    Prokhnevska, Nataliya
    Valanparambil, Rajesh
    Jansen, Caroline
    Master, Viraj
    Sanda, Martin
    Kissick, Haydn
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [23] Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model
    Xia, Yulong
    Ohno, Tatsukuni
    Nishii, Naoto
    Bhingare, Arundhati
    Tachinami, Hidetake
    Kashima, Yoshihisa
    Nagai, Shigenori
    Saito, Hirohisa
    Nakae, Susumu
    Azuma, Miyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 518 (02) : 331 - 336
  • [24] Drug-Loaded Tumor-Derived Microparticles Elicit CD8+T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma
    Chen, Yulin
    Zhang, Yi
    Wang, Jianjun
    Cai, Xiong
    Chen, Junzhang
    Min, Xiaobo
    Xu, Yunjie
    Qin, Qi
    Wan, Chidan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 2227 - 2239
  • [25] Synthetic IL-33 DNA as anti-tumor adjuvant in vivo.
    Villarreal, Daniel
    Wise, Megan
    Walters, Jewell
    Yan, Jian
    Morrow, Matthew P.
    Bagarazzi, Mark
    Sardesai, Niranjan
    Weiner, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Characterizing the role of IL-33/ST2 axis in regulating anti-tumor function by CD8 T cells during tumor metastasis in the omentum
    Desai, Sweta
    Meza-Perez, Selene
    Liu, Mingyong
    Randall, Troy D.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [27] Immunoswitch particles target activation of anti-tumor CD8+T cells to inhibit tumor growth
    Kosmides, Alyssa
    Sidhom, John-William
    Fraser, Andrew
    Bessell, Catherine
    Schneck, Jonathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [28] IL-37 mediates the anti-tumor activity in hepatocellular carcinoma via T cell activation and angiogenesis suppression
    Mei, Yu
    Teng, Wantian
    Teo, Huey Yee
    Liu, Haiyan
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [29] Induction of CD4+ and CD8+ anti-tumor effector T cell responses by bacteria mediated tumor therapy
    Stern, Christian
    Kasnitz, Nadine
    Kocijancic, Dino
    Trittel, Stephanie
    Riese, Peggy
    Guzman, Carlos A.
    Leschner, Sara
    Weiss, Siegfried
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (08) : 2019 - 2028
  • [30] Tumoral expression of IL-33 promotes Anti-tumor Immune Responses
    Wang, Xuefeng
    Gao, Xin
    Zhao, Xin
    Yang, Qianting
    Qi, Yuan
    Zang, Shayang
    Zhang, Xueguang
    Lu, Binfeng
    JOURNAL OF IMMUNOLOGY, 2014, 192
12345